On September 5, the 12th "China Charity Award" commendation conference, China's highest government award in the field of philanthropy, was held in the Great Hall of the People, commending units, individuals and charity projects that have made outstanding contributions in the field of philanthropy. 3SBio won this year’s “China Charity Award”.
The China Charity Award is the highest government award in the field of public welfare and charity in China. It was established in 2005 and sponsored by the Ministry of Civil Affairs. It aims to commend people who have contributed to disaster relief, helping the elderly, helping the disabled, rescuing orphans, relieving the poor, assisting students, assisting medical care, and supporting culture and art, Individuals, institutions and projects that have made outstanding contributions to environmental protection and other public welfare fields.
3SBio has always adhered to the concept of corporate social responsibility and is committed to solving patients' clinical medication problems. It has participated extensively and deeply in a number of public welfare activities, actively responded to the national call and helped patient groups improve their living conditions, and has been widely recognized by all sectors of society. This time, 3SBio won this year’s “China Charity Award” for its long-term persistence and investment in charity. Zhao Liang, member of the CPPCC of Liaoning Province and vice president of 3SBio, took the stage to receive the award on behalf of the company.
Zhao Liang, Vice President of 3SBio
3SBio's Philanthropy Road
Over the years, 3SBio has launched and funded a number of public welfare projects, helping millions of patients and families reduce their medication burden and effectively improving the accessibility of medicines.
In 2014, we cooperated with the Beijing Bethune Charity Foundation to launch the "Watching Happiness-Bethune·TBIAO Charity Donation Project" to help patients with immune thrombocytopenia. As of 2021, the project has been running for 7 years, with 41,000 patients donated, and the amount donated to TPIAO reaching 123 million yuan.
In 2015, the "Benefit + Hope-Bethune Yisaipu Donation Project" was launched to help ankylosis patients adhere to scientific treatment and improve their quality of life, benefiting 138,000 patients, and the donation amount reached 780 million yuan.
In 2019, we participated in the ankylosing spondylitis health poverty alleviation project initiated by the National Health Commission and the former State Council Poverty Alleviation Office (now the National Rural Revitalization Administration), donating 180 million yuan and 330,000 medicines, with the goal of treating 20,000 grassroots ankylosing patients. , and actively help the country move from poverty alleviation to rural revitalization.
In 2020, the "Public Benefit Life - Bethune-Septin Charity Donation Project" was launched, and a total of 12,000 medicines were donated to more than 1,400 patients, with a total value of donated medicines of 15.606 million yuan.
In 2023, it will donate 10 million yuan to the Liaoning Charity Federation to carry out the "breast cancer" patient relief project in Liaoning Province to help breast cancer patients and reduce the patients' treatment costs and drug financial burden.
In the future, 3SBio will continue to uphold its mission of “making innovative biopharmaceuticals within reach”, and while striving to build a world-leading Chinese biopharmaceutical company, it will also actively participate in public welfare and charity, continue to leverage its corporate advantages, fulfill its social responsibilities, and contribute to a better future. Bring hope to many patients and their families.